Chimin Health Management Co., Ltd. Provides Earnings Guidance for 2019
January 19, 2020
Share
Chimin Health Management Co., Ltd. provided earnings guidance for 2019. The company predicts that the net profit belonging to shareholders of the listed company will increase by RMB 33 million and RMB 39 million in 2019, with an increase of between 102.92% and 121.64% compared with the same period of the year before and the net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss in 2019 will increase by between RMB 100.68 million and RMB 106.68 million, the net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss turn loss to profit.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
CHIMIN HEALTH MANAGEMENT CO., LTD. 
